MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
166 hedge funds and large institutions have $1.05B invested in Momenta Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 68 increasing their positions, 44 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
23% less capital invested
Capital invested by funds: $1.36B → $1.05B (-$308M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
166
Holding in Top 10
–
Calls
$3.76M
Puts
$2.59M
Top Buyers
| 1 | +$21.3M | |
| 2 | +$10.7M | |
| 3 | +$9.53M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.47M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.21M |
Top Sellers
| 1 | -$13.7M | |
| 2 | -$9.25M | |
| 3 | -$8.67M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$6.91M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$6.57M |